Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin: 28
O'Carroll, A.M.; Lolait, S.J.; König, M.; Mahan, L.C.
Molecular Pharmacology 44(6): 1278
1993
ISSN/ISBN: 0026-895X PMID: 8264565 Document Number: 420104
Document emailed within 1 workday
Related Documents
Koc, E.U.; Ozgur, T.; Yerci, O.; Gurel, S. 2013: Somatostatin receptor 1 (SSTR1) and somatostatin receptor 5 (SSTR5)expression in hepatocellular carcinoma Hepato-Gastroenterology 60(127): 1693-1697Vainas, I.; Koussis, C.; Pazaitou-Panayiotou, K.; Drimonitis, A.; Chrisoulidou, A.; Iakovou, I.; Boudina, M.; Kaprara, A.; Maladaki, A. 2004: Somatostatin receptor expression in vivo and response to somatostatin analog therapy with or without other antineoplastic treatments in advanced medullary thyroid carcinoma Journal of Experimental and Clinical Cancer Research: Cr 23(4): 549-559
Gorden, P.; Comi, R.J.; Maton, P.N.; Go, V.L. 1989: NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut Annals of Internal Medicine 110(1): 35-50
Nikou, G.C.; Lygidakis, N.J.; Toubanakis, C.; Pavlatos, S.; Tseleni-Balafouta, S.; Giannatou, E.; Mallas, E.; Safioleas, M. 2005: Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues Hepato-Gastroenterology 52(63): 731-741
Jaquet, P.; Gunz, G.; Saveanu, A.; Barlier, A.; Dufour, H.; Taylor, J.; Dong, J.; Kim, S.; Moreau, J.P.; Culler, M.D. 2005: BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotide Journal of Endocrinological Investigation 28(11 Suppl International): 21-27
Chiewvit, S.; Chiewvit, P.; Pusuwan, P.; Sriussadaporn, S.; Ratanamart, V. 1999: Somatostatin receptor tumor imaging (Tc 99m P829) in pituitary adenoma Journal of the Medical Association of Thailand 82(12): 1208-1213
Kadar, T.; Redding, T.W.; Ben-David, M.; Schally, A.V. 1988: Decrease in prolactin receptor affinity in the rat mammary tumor model after treatment with analogs of somatostatin and LH-RH Materia Medica Polona. Polish Journal of Medicine and Pharmacy 20(4): 219-223
Buscail, L.; Saint-Laurent, N.; Chastre, E.; Vaillant, J.C.; Gespach, C.; Capella, G.; Kalthoff, H.; Lluis, F.; Vaysse, N.; Susini, C. 1996: Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer Cancer Research 56(8): 1823-1827
Reisine, T.; Wang, H.L.; Guild, S. 1988: Somatostatin inhibits cAMP-dependent and cAMP-independent calcium influx in the clonal pituitary tumor cell line AtT-20 through the same receptor population Journal of Pharmacology and Experimental Therapeutics 245(1): 225-231
Yoshioka, M. 1986: Elevation of somatostatin content, and reduction of somatostatin release by GABA in rat pancreatic islets Kobe Journal of Medical Sciences 32(1): 27-38
Padberg, W.M.; Morgalla, H.; Buhr, J.; Hild, P.; Schwemmle, K. 1991: Immunosuppressive action of somatostatin and the somatostatin analogue SMS 201-995 and their synergistic effect with low-dose cyclosporine a in organ transplantation Transplantation Proceedings 23(1 Part 1): 348
Whitehouse, I.; Beglinger, C.; Fried, M.; Gyr, K. 1984: The effect of an octapeptide somatostatin analogue (SMS 201-995) and somatostatin-14 (SST-14) on pentagastrin-stimulated gastric acid secretion: a comparative study in man Hepato-Gastroenterology 31(5): 227-229
Estève, J.P.; Susini, C.; Vaysse, N.; Gineston, J.L.; Pradayrol, L.; Wunsch, E.; Ribet, A. 1982: Effect of somatostatin 14, as natural and synthetic somatostatin 28 on pentagastrin-stimulated gastric acid and pancreatic secretions in conscious dogs Gastroenterologie Clinique et Biologique 6(6-7): 576-580
Claro, A.; Grill, V.; Efendić, S.; Luft, R. 1977: Studies on the mechanisms of somatostatin action on insulin release. IV. effect of somatostatin on cyclic AMP levels and phosphodiesterase activity in isolated rat pancreatic islets Acta Endocrinologica 85(2): 379-388
Baou, N.; Bouras, M.; Droz, J.P.; Dutrieux-Berger, N.; Bouvier, R.; Benahmed, M.; Krantic, S. 2001: Somatostatin receptor expression profile as a potential criterion for discrimination between seminoma and non-seminoma testicular tumors Cancer Detection and Prevention 25(5): 446-453
Granneman, J.G.; Lahners, K.N.; Chaudhry, A. 1991: Molecular cloning and expression of the rat beta 3-adrenergic receptor Molecular Pharmacology 40(6): 895-899
Sawano, S.; Kokubu, T.; Isizuka, Y. 1975: Effect of somatostatin on in vitro pituitary superfusion system in rats Nihon Rinsho. Japanese Journal of Clinical Medicine 33(3): 567-571
Saito, M.; Yoshida, K.; Hibi, M.; Taga, T.; Kishimoto, T. 1992: Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo Journal of Immunology 148(12): 4066-4071
Lis, M.; Motomatsu, T.; Chrétien, M. 1977: Effect of somatostatin on growth hormone release by MtT-F4 rat pituitary tumor in vitro Cancer Research 37(8 Part 1): 2612-2614
Bonn, U.; König, B. 1989: Distribution of somatostatin (SRIF) in the brain and pituitary of Eigenmannia lineata (Gymnotiformes, Teleostei). An immunohistochemical study Journal für Hirnforschung 30(2): 203-212